GDRX earnings date and last-quarter result: last quarter in line, P/E 50.00. Updated 2026-07-23.
GoodRx Holdings (GDRX) Research Hub
GoodRx Holdings (GDRX) trades on NASDAQ, US in the Healthcare (Medical - Healthcare Information Services) sector. As of 2026-10-26, shares last closed at 3.56 USD (+0.56%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 50.00, market cap 1.02B. This hub links to the full technical, earnings and options research available for GDRX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Information Services) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.56 USD (+0.56%) |
| 52-week range | 2.57 USD – 3.89 USD |
| Trend regime | Range |
| 14-day RSI | 64.8 (Bullish) |
| Trailing P/E | 50.00 |
| Market cap | 1.02B |
| Dividend yield | 0.00% |
Available research for GDRX
Covered Call on GDRX: how it works, illustrative setup around the real 3.56 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GDRX: how it works, illustrative setup around the real 3.56 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GDRX: how it works, illustrative setup around the real 3.56 USD price, max profit/loss, breakeven and when to use it. Educational.
GDRX technical analysis: range, last 3.56 USD, RSI 64.8, 52w range 2.57 USD–3.89 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is GDRX in?
GoodRx Holdings (GDRX) is classified under Healthcare (Medical - Healthcare Information Services), listed on NASDAQ, US.
Is GDRX in an uptrend or downtrend?
As of 2026-10-26, GDRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GDRX's trailing P/E ratio?
GDRX's trailing P/E is 50.00, with a market cap of 1.02B. See the earnings research page for full valuation detail.